Efficacy and safety of paliperidone palmitate in patients with schizophrenia upon admission to acute units

Trial Profile

Efficacy and safety of paliperidone palmitate in patients with schizophrenia upon admission to acute units

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 20 Sep 2016

At a glance

  • Drugs Paliperidone (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms SHADOW
  • Most Recent Events

    • 20 Sep 2016 Results of post-hoc analysis presented at the 29th Annual Congress of the European College of Neuropsychopharmacology
    • 12 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top